Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatitis | 2 | 2002 | 22 | 0.260 |
Why?
|
| Celiac Disease | 1 | 2002 | 10 | 0.220 |
Why?
|
| Digestive System | 1 | 2002 | 16 | 0.220 |
Why?
|
| Crohn Disease | 1 | 2002 | 46 | 0.210 |
Why?
|
| Colonoscopy | 1 | 2021 | 51 | 0.200 |
Why?
|
| Adenoma | 1 | 2021 | 42 | 0.190 |
Why?
|
| Food Hypersensitivity | 3 | 2014 | 57 | 0.190 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2014 | 88 | 0.180 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 220 | 0.170 |
Why?
|
| Hepatitis B Vaccines | 1 | 2014 | 7 | 0.130 |
Why?
|
| Hepatitis B | 1 | 2014 | 19 | 0.130 |
Why?
|
| Vaccination | 1 | 2014 | 41 | 0.130 |
Why?
|
| Toll-Like Receptors | 1 | 2014 | 28 | 0.120 |
Why?
|
| Cathartics | 1 | 2013 | 5 | 0.120 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 96 | 0.120 |
Why?
|
| Mannans | 1 | 2013 | 15 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2014 | 87 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2014 | 132 | 0.120 |
Why?
|
| Weight Loss | 1 | 2013 | 99 | 0.110 |
Why?
|
| Obesity | 1 | 2013 | 291 | 0.100 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2008 | 10 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2008 | 48 | 0.080 |
Why?
|
| Fermentation | 1 | 2007 | 12 | 0.080 |
Why?
|
| Dietary Fiber | 1 | 2007 | 22 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 66 | 0.070 |
Why?
|
| Enterocolitis | 1 | 2006 | 5 | 0.070 |
Why?
|
| Mastocytosis, Systemic | 1 | 2006 | 7 | 0.070 |
Why?
|
| Mast Cells | 1 | 2006 | 26 | 0.070 |
Why?
|
| Diarrhea | 1 | 2006 | 48 | 0.070 |
Why?
|
| Acute Disease | 2 | 2002 | 226 | 0.060 |
Why?
|
| Humans | 9 | 2021 | 29337 | 0.060 |
Why?
|
| Gastric Acid | 1 | 2002 | 10 | 0.050 |
Why?
|
| Surveys and Questionnaires | 1 | 2008 | 1184 | 0.050 |
Why?
|
| Adult | 5 | 2014 | 8601 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 148 | 0.050 |
Why?
|
| Permeability | 1 | 2002 | 134 | 0.050 |
Why?
|
| Liver Diseases | 1 | 2002 | 41 | 0.050 |
Why?
|
| Middle Aged | 5 | 2014 | 9823 | 0.050 |
Why?
|
| Observer Variation | 1 | 2021 | 118 | 0.050 |
Why?
|
| Biopsy | 1 | 2021 | 234 | 0.050 |
Why?
|
| Adolescent | 3 | 2013 | 2279 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 788 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 521 | 0.040 |
Why?
|
| Male | 5 | 2014 | 15621 | 0.040 |
Why?
|
| Female | 5 | 2014 | 16197 | 0.040 |
Why?
|
| Aged | 4 | 2014 | 9448 | 0.040 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2014 | 10 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2014 | 15 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 37 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 65 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2014 | 86 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2013 | 53 | 0.030 |
Why?
|
| Body Composition | 1 | 2013 | 56 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 264 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 142 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2013 | 159 | 0.030 |
Why?
|
| Prevalence | 1 | 2014 | 487 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 284 | 0.030 |
Why?
|
| Chicago | 1 | 2014 | 865 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 959 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2013 | 428 | 0.030 |
Why?
|
| Biomarkers | 1 | 2014 | 689 | 0.020 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2008 | 5 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 1932 | 0.020 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2008 | 7 | 0.020 |
Why?
|
| Gastrointestinal Motility | 1 | 2007 | 15 | 0.020 |
Why?
|
| Fatty Acids, Volatile | 1 | 2007 | 30 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2008 | 285 | 0.020 |
Why?
|
| Ranitidine | 1 | 2006 | 4 | 0.020 |
Why?
|
| Cetirizine | 1 | 2006 | 4 | 0.020 |
Why?
|
| Histamine H1 Antagonists, Non-Sedating | 1 | 2006 | 4 | 0.020 |
Why?
|
| Duodenum | 1 | 2006 | 12 | 0.020 |
Why?
|
| Tryptases | 1 | 2006 | 8 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2006 | 17 | 0.020 |
Why?
|
| Cell Count | 1 | 2006 | 99 | 0.020 |
Why?
|
| Asthma | 1 | 2008 | 138 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2014 | 3273 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 241 | 0.020 |
Why?
|
| Colon | 1 | 2006 | 148 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2006 | 495 | 0.010 |
Why?
|
| Depression | 1 | 2008 | 465 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2008 | 1811 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 2443 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 553 | 0.010 |
Why?
|
| Infant | 1 | 2002 | 531 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2002 | 642 | 0.010 |
Why?
|
| Prognosis | 1 | 2002 | 840 | 0.010 |
Why?
|
| Child | 1 | 2002 | 1346 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 4851 | 0.010 |
Why?
|
| Animals | 1 | 2007 | 4552 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 3478 | 0.010 |
Why?
|